ODDB.org: Open Drug Database

Home - 67689 - 01 - 001

DARZALEX SC 1800 mg/15 ml, Injektionslösung -

Swissmedic Key	67689001	Registration Holder	Janssen-Cilag AG
Name	DARZALEX SC 1800 mg/15 ml, Injektionslösung	Date of registration	13.08.2020
		Introduction of Sequence	13.08.2020
ATC-Classification	(L01FC01)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.10.	Show package size
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	4788.48	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	5220.80
Feedback	FB
GTIN	7680676890018	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

daratumumabum 1800 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, sorbitolum 735.1 mg, methioninum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 15 ml.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Daratumumabum	1800mg / 15ml

BAG: Active Agent	Dose
Daratumumabum	1800 mg

Inactive agents	Dose
Histidin Hydrochloride Monohydrate
Histidine
Hyaluronidasum Humanum Adnr
Methionine
Polysorbatum 20
Sorbitol	735.1mg / 15ml

Source

Data was imported : 04.04.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH